Goods and bads of the endocannabinoid system as a therapeutic target: Lessons learned after 30 years

M Maccarrone, V Di Marzo, J Gertsch, U Grether… - Pharmacological …, 2023 - ASPET
The cannabis derivative marijuana is the most widely used recreational drug in the Western
world and is consumed by an estimated 83 million individuals (∼ 3% of the world …

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

FA Iannotti, V Di Marzo, S Petrosino - Progress in lipid research, 2016 - Elsevier
The endocannabinoid system (ECS) is composed of two G protein-coupled receptors
(GPCRs), the cannabinoid CB1 and CB2 receptors, and the two main endogenous lipid …

Endocannabinoids, related compounds and their metabolic routes

F Fezza, M Bari, R Florio, E Talamonti, M Feole… - Molecules, 2014 - mdpi.com
Endocannabinoids are lipid mediators able to bind to and activate cannabinoid receptors,
the primary molecular targets responsible for the pharmacological effects of the Δ9 …

Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review

SD Skaper, L Facci, P Giusti - CNS & Neurological Disorders …, 2014 - ingentaconnect.com
Cells of the immune system and the central nervous system are capable of interacting with
each other. The former cell populations respond to infection, tissue injury and trauma by …

N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition

D Piomelli, L Scalvini, Y Fotio, A Lodola… - Journal of Medicinal …, 2020 - ACS Publications
N-Acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase primarily
found in the endosomal–lysosomal compartment of innate and adaptive immune cells …

Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors

W Tuo, N Leleu-Chavain, J Spencer… - Journal of medicinal …, 2017 - ACS Publications
Fatty acid ethanolamides (FAEs) and endocannabinoids (ECs) have been shown to
alleviate pain and inflammation, regulate motility and appetite, and produce anticancer …

Harnessing the anti-inflammatory potential of palmitoylethanolamide

M Alhouayek, GG Muccioli - Drug Discovery Today, 2014 - Elsevier
Highlights•PEA is an anti-inflammatory and neuroprotective compound.•Pharmacological
tools are available to control PEA levels via FAAH and NAAA inhibition.•FAAH and NAAA …

[HTML][HTML] N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis

M Alhouayek, P Bottemanne, KV Subramanian… - The FASEB …, 2015 - ncbi.nlm.nih.gov
N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory
compound that was recently shown to exert peroxisome proliferator-activated receptor-α …

Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation

S Pontis, A Ribeiro, O Sasso… - Critical reviews in …, 2016 - Taylor & Francis
Macrophages are multi-faceted phagocytic effector cells that derive from circulating
monocytes and undergo differentiation in target tissues to regulate key aspects of the …

A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation

A Ribeiro, S Pontis, L Mengatto, A Armirotti… - ACS chemical …, 2015 - ACS Publications
Fatty acid ethanolamides such as palmitoylethanolamide (PEA) and oleoylethanolamide
(OEA) are lipid-derived mediators that potently inhibit pain and inflammation by ligating type …